ChromaCode Inc, based in Carlsbad, CA, is dedicated to revolutionizing healthcare through their High-Definition PCR (HDPCR™) multiplexing technology. Their innovative platform empowers physicians and lab partners with faster results for enhanced decision-making, ultimately leading to improved patient outcomes.
By offering >4X multiplexing compared to traditional dPCR, ChromaCode's solutions enable unparalleled coverage of clinically relevant biomarkers, aligning with the National Comprehensive Cancer Network (NCCN) guidelines. With a turnaround time of <24 hours and automated interpretation via ChromaCode Cloud, their system requires zero hardware/software installation, ensuring scalability and regulatory compliance.
ChromaCode's HDPCR technology, designed for oncology and genomics, allows labs to conduct multi-analyte, high-content assays with ease. By simplifying molecular profiling through proprietary chemistry and software innovations, ChromaCode facilitates comprehensive DNA and RNA variant detection for tumor profiling, minimal residual disease (MRD) testing, and disease monitoring, offering cost-effective alternatives to conventional methods.
Generated from the website content
